Literature DB >> 35711828

Erratum: Overexpression of TC2N is associated with poor prognosis in gastric cancer: Erratum.

Jianbo Xu1, Xinde Ou1,2, Jin Li3,2, Qinbo Cai1,2, Kaiyu Sun1, Jingning Ye1, Jianjun Peng1.   

Abstract

[This corrects the article DOI: 10.7150/jca.50653.]. © The author(s).

Entities:  

Year:  2022        PMID: 35711828      PMCID: PMC9174853          DOI: 10.7150/jca.73345

Source DB:  PubMed          Journal:  J Cancer        ISSN: 1837-9664            Impact factor:   4.478


In our paper 1, the western blot band for TC2N in paired gastric cancer tissues and matched normal adjacent mucosa was used wrong in Figure 2E, so we replaced with the correct band. We are deeply sorry and sincerely apologize for the error and for any inconvenience that may cause to the readers and the editors of this journal. Figure 2E was corrected as follows.
Figure 2

High TC2N expression in gastric cancer. (A) Analysis of TC2N expression in unpaired GC (T = 408) and normal tissues (N = 211) in the GEPIA (P<0.05). (B, C) The measurements of TC2N expression in gastric cancer cell lines compared with the normal cell line GES1 by qRT-PCR(B) and WB(C). (D, E) The measurements of TC2N expression in 12 paired GC tissues and matched normal adjacent mucosa, analyzed by qRT-PCR(D) and WB(E). T, GC tissues; N, matched normal adjacent mucosa. *P < 0.05.

  1 in total

1.  Overexpression of TC2N is associated with poor prognosis in gastric cancer.

Authors:  Jianbo Xu; Xinde Ou; Jin Li; Qinbo Cai; Kaiyu Sun; Jingning Ye; Jianjun Peng
Journal:  J Cancer       Date:  2021-01-01       Impact factor: 4.207

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.